Hytrin

Known as: Hytrine, Flotrin, Deflox 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2012
012319872012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
AIM To assess differences in pupil diameter between men taking systemic α(1)-adrenoreceptor antagonists and controls. SETTING… (More)
Is this relevant?
2003
2003
PURPOSE The objective of this meta-analysis of randomized controlled trials (RCTs) of terazosin versus placebo in men with benign… (More)
Is this relevant?
1998
1998
AIMS A radioreceptor assay has been developed for alpha1-adrenoceptor subtypes and applied to a pharmacokinetic analysis of… (More)
Is this relevant?
1997
Review
1997
Review
1997
The importance of reporting correlations among side effects is examined using studies of BPH drugs as examples. The special… (More)
Is this relevant?
1996
1996
OBJECTIVES To determine the clinical effectiveness and safety of alpha(1)-blockade therapy versus placebo in the treatment of men… (More)
Is this relevant?
1995
1995
BPH is a diagnosis that needs to be considered and evaluated in older male renal disease/failure patients. Rather than proceeding… (More)
Is this relevant?
Review
1992
Review
1992
Terazosin (Hytrin; Abbott Laboratories, North Chicago, IL) is a new, selective alpha 1-adrenoceptor blocking agent used on once-a… (More)
Is this relevant?
1991
1991
The prescribing and usage patterns of two antihypertensive agents, terazosin (Hytrin) and enalapril maleate (Vasotec) were… (More)
Is this relevant?
1989
1989
Several reports in the literature suggest that alpha-receptor blockade may have therapeutic value in treating the symptoms of… (More)
Is this relevant?